Some earlier Phase 1 data tested 1mg starts, but the standard Phase 2 protocol that produced the most robust data used 2mg as the initial dose with escalation every four weeks
12,13,14,15,16,17 Unfortunately, for much of the subsequent 20th century, these concepts became superseded by the neurone doctrine, such that glial responses to CNS disorders were considered to be non-specific, stereotypic, always subsequent to primary neuronal damage and of little functional consequence
BPC-157 for Achilles Tendon Achilles tendon healing is one of BPC-157's most studied applications
Prescription drug costs top employer health concerns as GLP-1 coverage expands despite financial strain Large employers cite medication expenses as their biggest financial challenge, with many reconsidering coverage of costly GLP-1 weight loss drugs despite worker demand